MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway

Molecular Biology of the Cell

Volumn 24, Issue 1, 2013, Pages 42-55

  Xu, Lin ^a   Wen, Zhenke ^b   Zhou, Ya ^a   Liu, Zhongmin ^c   Li, Qinchuan ^c   Fei, Guangru ^c   Luo, Junmin ^a   Ren, Tao ^c  

^a ZUNYI MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 7; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT 3; PROTEIN KINASE B; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LUNG CANCER; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM METASTASIS; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84871903166     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E12-07-0519     Document Type: Article

References (52)

1. Ahmad R, Sylvester J, Zafarullah M (2007). MyD88, IRAK1 and TRAF6 knockdown in human chondrocytes inhibits interleukin-1-induced matrix metalloproteinase-13 gene expression and promoter activity by impairing MAP kinase activation. Cell Signal 19, 2549-2557. (Pubitemid 47531934)
2. Bhattacharya D, Yusuf N (2012). Expression of toll-like receptors on breast tumors: taking a toll on tumor microenvironment. Int J Breast Cancer 2012, 716564.
3. Bomben R et al. (2012). The miR-17-92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes. Leukemia 26, 1584-1593.
4. Cammarota R et al. (2010). The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker. J Transl Med 8, 112.
5. Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, Pierre P (2009). MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci USA 106, 2735-2740.
6. Chen R, Alvero AB, Silasi DA, Kelly MG, Fest S, Visintin I, Leiser A, Schwartz PE, Rutherford T, Mor G (2008a). Regulation of IKKaß by miR-199a affects NF-κB activity in ovarian cancer cells. Oncogene 27, 4712-4723.
7. Chen R, Alvero AB, Silasi DA, Steffensen KD, Mor G (2008b). Cancers take their Toll - the function and regulation of Toll-like receptors in cancer cells. Oncogene 27, 225-233.
8. Creagh EM, O'Neill LA (2006). TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 27, 352-357. (Pubitemid 44038661)
9. Droemann D, Albrecht D, Gerdes J, Ulmer AJ, Branscheid D, Vollmer E, Dalhoff K, Zabel P, Goldmann T (2005). Human lung cancer cells express functionally active Toll-like receptor 9. Respir Res 6, 1.
10. Esquela-Kerscher A, Slack FJ (2006). Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6, 259-269.
11. Fang Y, Xue JL, Shen Q, Chen J, Tian L (2012). miR-7 inhibits tumor growth and metastasis by targeting the PI3K/AKT pathway in hepatocellular carcinoma. Hepatology 55, 1852-1862.
12. González-Reyes S, Fernández JM, González LO, Aguirre A, Suárez A, González JM, Escaff S, Vizoso FJ (2011). Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurence. Cancer Immunol Immunother 60, 217-226.
13. Guo D, Ye J, Dai J, Li L, Chen F, Ma D, Ji C (2009). Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines. Leuk Res 33, 678-685.
14. He W, Liu Q, Wang L, Chen W, Li N, Cao X (2007). TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 44, 2850-2859. (Pubitemid 46412506)
15. Hu J, Xia X, Cheng A, Wang G, Luo X, Reed MF, Fojo T, Oetting A, Gong J, Yen PM (2008). A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapy. Mol Cancer Ther 7, 3719-3728.
16. Huang B, Zhao J, Li H, He KL, Chen Y, Chen SH, Mayer L, Unkeless JC, Xiong H (2005). Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 65, 5009-5014. (Pubitemid 40827306)
17. Ioannou S, Voulgarelis M (2011). Toll-like receptors, tissue injury, and tumourigenesis. Mediators Inflamm. doi:10.1155/2010/581837.
18. Kirigin FF et al. (2012). Dynamic microRNA gene transcription and processing during T cell development. J Immunol 188, 3257-3267.
19. Kong D et al. (2011a). Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells. Mol Cancer Ther 10, 1720-1727.
20. Kong D et al. (2011b). Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells. Oncogene 31, 3949-3960.
21. Lecomte N, Njardarson JT, Nagorny P, Yang G, Downey R, Ouerfelli O, Moore MA, Danishefsky SJ (2011). Emergence of potent inhibitors of metastasis in lung cancer via syntheses based on migrastatin. Proc Natl Acad Sci USA 108, 15074-15078.
22. Lim EJ, Park DW, Jeong TW, Chin BR, Bae YS, Baek SH (2012). TRAIL is involved in CpG ODN-mediated anti-apoptotic signals. Oncol Rep 27, 1213-1218.
23. Lin P, Sun X, Feng T, Zou H, Jiang Y, Liu Z, Zhao D, Yu X (2012). ADAM17 regulates prostate cancer cell proliferation through mediating cell cycle progression by EGFR/PI3K/AKT pathway. Mol Cell Biochem 359, 235-243.
24. Liu G, Friggeri A, Yang Y, Park YJ, Tsuruta Y, Abraham E (2009). miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci USA 106, 15819-15824.
25. Majumder S, Jacob ST (2011). Emerging role of microRNAs in drug-resistant breast cancer. Gene Expr 15, 141-151.
26. Min R, Zun Z, Siyi L, Wenjun Y, Lizheng W, Chenping Z (2011). Increased expression of Toll-like receptor-9 has close relation with tumour cell proliferation in oral squamous cell carcinoma. Arch Oral Biol 56, 877-884.
27. Mínguez B, Lachenmayer A (2011). Diagnostic and prognostic molecular markers in hepatocellular carcinoma. Dis Markers 31, 181-190.
28. Nahid MA, Satoh M, Chan EK (2011). Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J Immunol 186, 1723-1734.
29. Patron JP et al. (2012). MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis. PloS One 7, e35345.
30. Pinto A, Morello S, Sorrentino R (2011). Lung cancer and Toll-like receptors. Cancer Immunol Immunother 60, 1211-1220.
31. Ravindran C, Cheng YC, Liang SM (2010). CpG-ODNs induces up-regulated expression of chemokine CCL9 in mouse macrophages and microglia. Cell Immunol 260, 113-118.
32. Rebane A (2011). microRNA expression profiles of human blood monocyte derived dendritic cells and macrophages reveal miR-511 as putative positive regulator of TLR4. J Biol Chem 286, 26487-26495.
33. Reddy SD, Ohshiro K, Rayala SK, Kumar R (2008). MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res 68, 8195-8200.
34. Ren T, Wen ZK, Liu ZM, Liang YJ, Guo ZL, Xu L (2007). Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell. Cancer Biol Ther 6, 1704-1709. (Pubitemid 351590304)
35. Ren T, Xu L, Jiao S, Wang Y, Cai Y, Liang Y, Zhou Y, Zhou H, Wen Z (2009). TLR9 signaling promotes tumor progression of human lung cancer cell in vivo. Pathol Oncol Res 15, 623-630.
36. Samara KD, Antoniou KM, Karagiannis K, Margaritopoulos G, Lasithiotaki I, Koutala E, Siafakas NM (2012). Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis. Int J Saydam O et al. 40, 1397-1404.
37. Saydam O et al. (2011). miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways. Cancer Res 71, 852-861.
38. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q, Johnson DS, Chen Y, O'Neill LA (2010). Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11, 141-147.
39. Song C, Chen LZ, Zhang RH, Yu XJ, Zeng YX (2006). Functional variant in the 3′-untranslated region of Toll-like receptor 4 is associated with nasopharyngeal carcinoma risk. Cancer Biol Ther 5, 1285-1291. (Pubitemid 44772253)
40. Soroceanu L et al. (2007). Identification of IGF2 signaling through phosphoinositide- 3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma. Proc Natl Acad Sci USA 104, 3466-3471. (Pubitemid 46364182)
41. Sorrentino R, Morello S, Giordano MG, Arra C, Maiolino P, Adcock IM, Pinto A (2011). CpG-ODN increases the release of VEGF in a mouse model of lung carcinoma. Int J Cancer 128, 2815-2822.
42. Troutman TD, Hu W, Fulenchek S, Yamazaki T, Kurosaki T, Bazan JF, Pasare C (2012). Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt. Proc Natl Acad Sci USA 109, 273-278.
43. Tserel L, Runnel T, Kisand K, Pihlap M, Bakhoff L, Kolde R, Peterson H, Vilo J, Peterson P, Rebane A (2011). MicroRNA expression profiles of human blood monocyte-derived dendritic cells and macrophages reveal miR-511 as putative positive regulator of Toll-like receptor 4. J Biol Chem 286, 26487-26495.
44. Tsushima F, Tanaka K, Otsuki N, Youngnak P, Iwai H, Omura K, Azuma M (2006). Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma. Oral Oncol 42, 268-274. (Pubitemid 43246758)
45. Wang CC, Zeng Q, Hwang LA, Guo K, Li J, Liew HC, Hong W (2006). Mouse lymphomas caused by an intron-splicing donor site deletion of the FasL gene. Biochem Biophys Res Commun 349, 50-58. (Pubitemid 44331761)
46. Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, Leedman PJ (2009). Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J Biol Chem 284, 5731-5741.
47. Wendlandt EB, Graff JW, Gioannini TL, McCaffrey AP, Wilson ME (2012). The role of microRNAs miR-200b and miR-200c in TLR4 signaling and NF-κB activation. Innate Immun, doi: 10.1177/1753425912443903.
48. Xiong S, Zheng Y, Jiang P, Liu R, Liu X, Chu Y (2011). MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2. Int J Biol Sci 7, 805-814.
49. Xu L, Wang C, Wen Z, Yao X, Liu Z, Li Q, Wu Z, Xu Z, Liang Y, Ren T (2010a). Selective upregulation of CDK2 is critical for TLR9 signaling stimulated proliferation of human lung cancer cell. Immunol Lett 127, 93-99.
50. Xu L, Wang C, Wen Z, Zhou Y, Liu Z, Liang Y, Xu Z, Ren T (2010b). CpG oligodeoxynucleotides enhance the efficacy of adoptive cell transfer using tumor infiltrating lymphocytes by modifying the Th1 polarization and local infiltration of Th17 cells. Clin Dev Immunol 2010, 410893.
51. Xu L, Zhou Y, Liu Q, Luo JM, Qing M, Tang XY, Yao XS, Wang CH, Wen ZK (2009). CXCR4/SDF-1 pathway is crucial for TLR9 agonist enhanced metastasis of human lung cancer cell. Biochem Biophys Res Commun 382, 571-576.
52. Zhang L et al. (2007). Integrative genomic analysis of phosphatidylinositol 3′-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer. Clin Cancer Res 13, 5314-5321. (Pubitemid 47510355)